1. Igarashi T., Ito S., Sako M., Saitoh A., Hataya H., Mizuguchi M., Morishima T., Ohnishi K., Kawamura N., Kitayama H., Ashida A., Kaname S., Taneichi H., Tang J., Ohnishi M.; Study group for establishing guidelines for the diagnosis and therapy of hemolytic uremic syndrome. Guidelines for the management and investigation of hemolytic uremic syndrome // Clin Exp Nephrol. – 2014. – Aug; 18(4): 525-57.
2. Scully M., Cataland S., Coppo P., De la Rubia J., Friedman K.D., Kremer Hovinga J., Lämmle B., Matsumoto M., Pavenski K., Sadler E., Sarode R., Wu H.; International Working Group for Thrombotic Thrombocytopenic Purpura.. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies // J Thromb Haemost. – 2017. – Feb; 15(2): 312-320.
3. Contreras E., De la Rubia J., Del Río-Garma J., Díaz-Ricart M., García-Gala J.M., Lozano M.; Grupo Español de Aféresis. Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group // Med Clin (Barc). – 2015. – Apr 8; 144(7): 331.e1-331.
4. Козловская Н.Л., Коротчаева Ю.В., Боброва Л.А., Шилов Е.М. Акушерский атипичный гемолитико-уремический синдром: первый российский опыт диагностики и лечения // Нефрология. – 2016. – 20(2): 68-81.
5. Clark W.F., Patriquin C., Licht C., Huang S.H., Rock G.A. Simple diagnosis and treatment algorithm for adult thrombotic microangiopathy // Transfus Apher Sci. – 2016. – Dec 31. pii: S1473-0502(16)30204-X.
6. Appel G.B. Thrombotic microangiopathies: Similar presentations, different therapies // Cleve Clin J Med. – 2017. – Feb; 84(2): 114-130.
7. Shatzel J.J., Taylor J.A. Syndromes of Thrombotic Microangiopathy // Med Clin North Am. – 2017. – Mar; 101(2): 395-415.
8. Sawai T., Nangaku M., Ashida A., et al. Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society. Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society // Clin Exp Nephrol. – 2014. – Feb; 18(1): 4-9.
9. Mannucci P.M., Cugno M. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring // Thromb Res. – 2015. – Nov; 136(5): 851-854.
10. Azzoug S., Chentli F. Microangiopathy and pregnancy // J Pak Med Assoc. – 2016. – Sep; 66(9 Suppl 1): S52-55.
11. Fakhouri F. Pregnancy-related thrombotic microangiopathies: Clues from complement biology // Transfus Apher Sci. – 2016. – Apr; 54(2): 199-202.
12. Thomas M.R., Robinson S., Scully M.A. How we manage thrombotic microangiopathies in pregnancy // Br J Haematol. – 2016. – Jun; 173(6): 821-830.
13. Pérez-Calatayud Á.A., Briones-Garduño J.C., Álvarez-Goris Mdel P., Sánchez Zamora R., Torres Aguilar A.A., Mendoza-Mórales R.E. Atipical uremic hemolityc syndrome in pregnancy // Cir Cir. – 2016. – Jul-Aug; 84(4): 344-349.
14. Гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Преэклампсия. Эклампсия. Клинические рекомендации (протокол лечения). Министерство здравоохранения Российской Федерации № 15-4/10/2-3483 от 07.06.2016 – 72 с.
15. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy // Am J Obstet Gynecol. – 1982. – Jan 15; 142(2): 159-167.
16. National Clinical Guideline Centre (UK). Acute Kidney Injury: Prevention, Detection and Management Up to the Point of Renal Replacement Therapy [Internet]. – London: Royal College of Physicians (UK); 2013 Aug.
17. Приказ Министерства Здравоохранения Российской Федерации от 02 апреля 2013 г. № 183н «Об утверждении правил клинического использования донорской крови и (или) ее компонентов».
18. Demir E., Yazici H., Ozluk Y., Kilicaslan I., Turkmen A. Pregnant Woman with Atypical Hemolytic Uremic Syndrome Delivered a Healthy Newborn under Eculizumab Treatment // Case Rep Nephrol Dial. – 2016. – Dec 20; 6(3): 143-148.
19. Gately R., San A., Kurtkoti J., Parnham A. Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab // Nephrology (Carlton). – 2017. – Feb; 22 Suppl 1: 32-35.
20. Fakhouri F., Delmas Y., Provot F., et al. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases // AJKD. – 2013. – http://dx.doi. org/10.1053/ j.ajkd.2013.07.011.
21. Zuber J., Fakhouri F., Roumenina L.T., et al. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopahties // Nat. Rev. Nephrol. – 2012. – 8, 643-657.
22. Delaney M., Wendel S., Bercovitz R.S., Cid J., et al.; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Transfusion reactions: prevention, diagnosis, and treatment // Lancet. – 2016. – Dec 3; 388(10061): 2825-2836.